Who invested in Sharp Edge Labs

3 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$950Kraised across 3 rounds since 2012, from 3 sources

$100KVenture$250KSeed$600KSeries B

Latest round: Series B, $600KAug 2014
Step-upi: 2.4×
Investors: 2

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201220132014

$100KVenture$250KSeed$600KSeries B

First round: Venture, $100K
Biggest round: $600K
Usual gap between rounds: 18 months

The rounds

Aug 2014
Series B$600K2 new
- Innovation Works
- Newlin Investment Company
From a historical funding record
Jul 2013
Seed$250K
No investor was named in the report.
Reported by sec.govSEC filing: $250K sold, first sale Jun 2013
Jan 2012
Venture$100K
No investor was named in the report.
Reported by sec.govSEC filing: $100K sold, first sale Dec 2011

Founders and team

From the SEC filings it signed: 2 on the team.

Marcel F. BruchezExecutive Officer, Directori
Scott F. SneddonExecutive Officer, Directori

On the board, as filediStephan R. DietrichWilliam R. Newlin

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2012Seed2013Series B2014

Innovation Works

Newlin Investment Company

Everyone who backed them

Innovation WorksGovernment1round

Newlin Investment CompanyPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Sharp Edge Labs as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.